Annual CFO
-$5.25 M
+$15.03 M+74.12%
December 31, 2023
Summary
- As of February 8, 2025, APYX annual cash flow from operations is -$5.25 million, with the most recent change of +$15.03 million (+74.12%) on December 31, 2023.
- During the last 3 years, APYX annual CFO has risen by +$10.82 million (+67.33%).
- APYX annual CFO is now -275.78% below its all-time high of $2.99 million, reached on December 31, 2006.
Performance
APYX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.44 M
-$111.00 K-2.56%
September 30, 2024
Summary
- As of February 8, 2025, APYX quarterly cash flow from operations is -$4.44 million, with the most recent change of -$111.00 thousand (-2.56%) on September 30, 2024.
- Over the past year, APYX quarterly CFO has increased by +$1.90 million (+29.98%).
- APYX quarterly CFO is now -220.13% below its all-time high of $3.70 million, reached on September 30, 2023.
Performance
APYX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$17.32 M
-$8.14 M-88.57%
September 30, 2024
Summary
- As of February 8, 2025, APYX TTM cash flow from operations is -$17.32 million, with the most recent change of -$8.14 million (-88.57%) on September 30, 2024.
- Over the past year, APYX TTM CFO has dropped by -$7.61 million (-78.41%).
- APYX TTM CFO is now -680.05% below its all-time high of $2.99 million, reached on December 31, 2006.
Performance
APYX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APYX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +74.1% | +30.0% | -78.4% |
| 3 y3 years | +67.3% | -23.2% | -48.3% |
| 5 y5 years | +74.9% | +2.4% | +6.2% |
APYX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.1% | -220.1% | +30.0% | -230.0% | +14.6% |
| 5 y | 5-year | at high | +74.1% | -220.1% | +40.1% | -230.0% | +16.7% |
| alltime | all time | -275.8% | +74.9% | -220.1% | +75.4% | -680.0% | +47.9% |
Apyx Medical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.44 M(+2.6%) | -$17.32 M(+88.6%) |
| Jun 2024 | - | -$4.33 M(-31.7%) | -$9.19 M(-5.4%) |
| Mar 2024 | - | -$6.34 M(+186.7%) | -$9.71 M(+85.0%) |
| Dec 2023 | -$5.25 M(-74.1%) | -$2.21 M(-159.8%) | -$5.25 M(-30.6%) |
| Sep 2023 | - | $3.70 M(-176.2%) | -$7.57 M(-54.5%) |
| Jun 2023 | - | -$4.85 M(+157.9%) | -$16.62 M(-5.8%) |
| Mar 2023 | - | -$1.88 M(-58.5%) | -$17.64 M(-13.0%) |
| Dec 2022 | -$20.28 M(+94.1%) | -$4.53 M(-15.5%) | -$20.28 M(+30.5%) |
| Sep 2022 | - | -$5.36 M(-8.7%) | -$15.54 M(+12.7%) |
| Jun 2022 | - | -$5.87 M(+30.0%) | -$13.78 M(+6.7%) |
| Mar 2022 | - | -$4.52 M(-2211.2%) | -$12.91 M(+23.6%) |
| Dec 2021 | -$10.45 M(-35.0%) | $214.00 K(-105.9%) | -$10.45 M(-10.5%) |
| Sep 2021 | - | -$3.60 M(-28.0%) | -$11.68 M(+9.3%) |
| Jun 2021 | - | -$5.01 M(+144.0%) | -$10.69 M(-0.2%) |
| Mar 2021 | - | -$2.05 M(+101.8%) | -$10.71 M(-33.3%) |
| Dec 2020 | -$16.07 M(-13.0%) | -$1.02 M(-61.1%) | -$16.07 M(-12.2%) |
| Sep 2020 | - | -$2.62 M(-48.0%) | -$18.30 M(-9.6%) |
| Jun 2020 | - | -$5.03 M(-32.1%) | -$20.23 M(-2.7%) |
| Mar 2020 | - | -$7.41 M(+127.8%) | -$20.79 M(+12.5%) |
| Dec 2019 | -$18.48 M(-11.5%) | -$3.25 M(-28.5%) | -$18.48 M(-44.5%) |
| Sep 2019 | - | -$4.55 M(-18.6%) | -$33.27 M(+11.4%) |
| Jun 2019 | - | -$5.59 M(+9.8%) | -$29.88 M(+20.2%) |
| Mar 2019 | - | -$5.09 M(-71.8%) | -$24.86 M(+19.1%) |
| Dec 2018 | -$20.88 M(+463.7%) | -$18.05 M(+1463.8%) | -$20.88 M(+892.4%) |
| Sep 2018 | - | -$1.15 M(+101.4%) | -$2.10 M(+41.1%) |
| Jun 2018 | - | -$573.00 K(-48.3%) | -$1.49 M(-25.2%) |
| Mar 2018 | - | -$1.11 M(-251.6%) | -$1.99 M(-46.2%) |
| Dec 2017 | -$3.70 M(+30.6%) | $731.00 K(-235.1%) | -$3.70 M(-25.6%) |
| Sep 2017 | - | -$541.00 K(-49.7%) | -$4.98 M(+14.4%) |
| Jun 2017 | - | -$1.08 M(-61.8%) | -$4.35 M(+28.4%) |
| Mar 2017 | - | -$2.82 M(+418.0%) | -$3.39 M(+19.4%) |
| Dec 2016 | -$2.84 M(-51.0%) | -$544.00 K(-725.3%) | -$2.84 M(-14.4%) |
| Sep 2016 | - | $87.00 K(-177.0%) | -$3.31 M(-18.1%) |
| Jun 2016 | - | -$113.00 K(-95.0%) | -$4.04 M(-35.4%) |
| Mar 2016 | - | -$2.27 M(+122.0%) | -$6.26 M(+8.2%) |
| Dec 2015 | -$5.79 M(+1287.5%) | -$1.02 M(+58.5%) | -$5.79 M(+26.7%) |
| Sep 2015 | - | -$644.00 K(-72.4%) | -$4.57 M(+41.6%) |
| Jun 2015 | - | -$2.33 M(+30.1%) | -$3.23 M(+178.3%) |
| Mar 2015 | - | -$1.79 M(-1004.5%) | -$1.16 M(+177.9%) |
| Dec 2014 | -$417.00 K(-83.6%) | $198.00 K(-71.6%) | -$417.00 K(-78.7%) |
| Sep 2014 | - | $698.00 K(-364.4%) | -$1.96 M(-24.0%) |
| Jun 2014 | - | -$264.00 K(-74.8%) | -$2.58 M(-22.5%) |
| Mar 2014 | - | -$1.05 M(-22.1%) | -$3.33 M(+31.4%) |
| Dec 2013 | -$2.54 M(-1637.0%) | -$1.35 M(-1826.9%) | -$2.54 M(+115.3%) |
| Sep 2013 | - | $78.00 K(-107.7%) | -$1.18 M(-24.3%) |
| Jun 2013 | - | -$1.01 M(+300.8%) | -$1.56 M(-491.0%) |
| Mar 2013 | - | -$253.00 K(-2400.0%) | $398.00 K(+141.2%) |
| Dec 2012 | $165.00 K(-91.3%) | $11.00 K(-103.7%) | $165.00 K(-275.5%) |
| Sep 2012 | - | -$300.00 K(-131.9%) | -$94.00 K(-170.1%) |
| Jun 2012 | - | $940.00 K(-293.4%) | $134.00 K(-80.1%) |
| Mar 2012 | - | -$486.00 K(+96.0%) | $674.00 K(-64.5%) |
| Dec 2011 | $1.90 M | -$248.00 K(+244.4%) | $1.90 M(-26.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$72.00 K(-104.9%) | $2.57 M(+27.1%) |
| Jun 2011 | - | $1.48 M(+100.8%) | $2.02 M(-704.2%) |
| Mar 2011 | - | $737.00 K(+72.2%) | -$335.00 K(-36.3%) |
| Dec 2010 | -$526.00 K(+442.3%) | $428.00 K(-168.9%) | -$526.00 K(-64.3%) |
| Sep 2010 | - | -$621.00 K(-29.4%) | -$1.47 M(+79.3%) |
| Jun 2010 | - | -$879.00 K(-261.0%) | -$820.90 K(-516.5%) |
| Mar 2010 | - | $546.00 K(-205.4%) | $197.10 K(-303.2%) |
| Dec 2009 | -$97.00 K(-113.1%) | -$518.10 K(-1815.6%) | -$97.00 K(-63.5%) |
| Sep 2009 | - | $30.20 K(-78.3%) | -$266.10 K(-162.4%) |
| Jun 2009 | - | $139.00 K(-44.8%) | $426.30 K(-25.4%) |
| Mar 2009 | - | $251.90 K(-136.7%) | $571.30 K(-23.1%) |
| Dec 2008 | $742.80 K(-64.5%) | -$687.20 K(-195.1%) | $742.90 K(-70.9%) |
| Sep 2008 | - | $722.60 K(+154.4%) | $2.55 M(+23.0%) |
| Jun 2008 | - | $284.00 K(-32.9%) | $2.07 M(-6.6%) |
| Mar 2008 | - | $423.50 K(-62.1%) | $2.22 M(+6.1%) |
| Dec 2007 | $2.09 M(-30.0%) | $1.12 M(+356.1%) | $2.09 M(+4.0%) |
| Sep 2007 | - | $245.30 K(-43.1%) | $2.01 M(-18.9%) |
| Jun 2007 | - | $431.30 K(+45.7%) | $2.48 M(-8.5%) |
| Mar 2007 | - | $296.10 K(-71.5%) | $2.71 M(-9.4%) |
| Dec 2006 | $2.99 M(-1675.0%) | $1.04 M(+45.6%) | $2.99 M(+47.3%) |
| Sep 2006 | - | $712.80 K(+7.9%) | $2.03 M(+26.5%) |
| Jun 2006 | - | $660.50 K(+14.8%) | $1.60 M(+483.2%) |
| Mar 2006 | - | $575.40 K(+625.6%) | $274.90 K(-245.1%) |
| Dec 2005 | -$189.60 K(-109.3%) | $79.30 K(-72.5%) | -$189.50 K(<-9900.0%) |
| Sep 2005 | - | $288.10 K(-143.1%) | $1600.00(-99.7%) |
| Jun 2005 | - | -$667.90 K(-701.7%) | $626.70 K(-67.1%) |
| Mar 2005 | - | $111.00 K(-58.9%) | $1.91 M(-6.7%) |
| Dec 2004 | $2.04 M(+123.3%) | $270.40 K(-70.4%) | $2.04 M(+18.2%) |
| Sep 2004 | - | $913.20 K(+49.1%) | $1.73 M(+55.2%) |
| Jun 2004 | - | $612.50 K(+147.1%) | $1.11 M(-14.0%) |
| Mar 2004 | - | $247.90 K(-663.4%) | $1.30 M(+41.6%) |
| Dec 2003 | $915.30 K(+1136.9%) | -$44.00 K(-114.8%) | $915.30 K(-30.0%) |
| Sep 2003 | - | $297.90 K(-62.5%) | $1.31 M(+10.2%) |
| Jun 2003 | - | $794.40 K(-697.3%) | $1.19 M(+479.1%) |
| Mar 2003 | - | -$133.00 K(-138.1%) | $205.00 K(+177.4%) |
| Dec 2002 | $74.00 K(-92.1%) | $349.00 K(+97.4%) | $73.90 K(-53.0%) |
| Sep 2002 | - | $176.80 K(-194.1%) | $157.30 K(-21.9%) |
| Jun 2002 | - | -$187.80 K(-28.9%) | $201.40 K(-62.7%) |
| Mar 2002 | - | -$264.10 K(-161.1%) | $539.50 K(-42.6%) |
| Dec 2001 | $940.80 K(+43.1%) | $432.40 K(+95.7%) | $940.70 K(+35.6%) |
| Sep 2001 | - | $220.90 K(+47.0%) | $693.70 K(+21.6%) |
| Jun 2001 | - | $150.30 K(+9.6%) | $570.60 K(+8.4%) |
| Mar 2001 | - | $137.10 K(-26.1%) | $526.40 K(-19.9%) |
| Dec 2000 | $657.50 K(+23.9%) | $185.40 K(+89.6%) | $657.50 K(+39.3%) |
| Sep 2000 | - | $97.80 K(-7.8%) | $472.10 K(+26.1%) |
| Jun 2000 | - | $106.10 K(-60.4%) | $374.30 K(+39.6%) |
| Mar 2000 | - | $268.20 K | $268.20 K |
| Dec 1999 | $530.70 K(-3890.7%) | - | - |
| Dec 1998 | -$14.00 K(-85.8%) | - | - |
| Dec 1997 | -$98.80 K(-123.2%) | - | - |
| Dec 1996 | $425.30 K(+3302.4%) | - | - |
| Dec 1995 | $12.50 K | - | - |
FAQ
- What is Apyx Medical annual cash flow from operations?
- What is the all time high annual CFO for Apyx Medical?
- What is Apyx Medical annual CFO year-on-year change?
- What is Apyx Medical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Apyx Medical?
- What is Apyx Medical quarterly CFO year-on-year change?
- What is Apyx Medical TTM cash flow from operations?
- What is the all time high TTM CFO for Apyx Medical?
- What is Apyx Medical TTM CFO year-on-year change?
What is Apyx Medical annual cash flow from operations?
The current annual CFO of APYX is -$5.25 M
What is the all time high annual CFO for Apyx Medical?
Apyx Medical all-time high annual cash flow from operations is $2.99 M
What is Apyx Medical annual CFO year-on-year change?
Over the past year, APYX annual cash flow from operations has changed by +$15.03 M (+74.12%)
What is Apyx Medical quarterly cash flow from operations?
The current quarterly CFO of APYX is -$4.44 M
What is the all time high quarterly CFO for Apyx Medical?
Apyx Medical all-time high quarterly cash flow from operations is $3.70 M
What is Apyx Medical quarterly CFO year-on-year change?
Over the past year, APYX quarterly cash flow from operations has changed by +$1.90 M (+29.98%)
What is Apyx Medical TTM cash flow from operations?
The current TTM CFO of APYX is -$17.32 M
What is the all time high TTM CFO for Apyx Medical?
Apyx Medical all-time high TTM cash flow from operations is $2.99 M
What is Apyx Medical TTM CFO year-on-year change?
Over the past year, APYX TTM cash flow from operations has changed by -$7.61 M (-78.41%)